A high dose of famotidine, commonly known as Pepcid®, was found to have beneficial effects in adult patients with coronavirus disease 2019 (COVID-19), according to results of an outpatient clinical trial. Patients who took famotidine in this trial experienced a decrease of inflammation within the body and reported earlier alleviation of symptoms. Findings from the … Continue reading Famotidine clinical trial shows COVID-19 symptom reduction